Managing editor @statnews, ex @washingtonpost editor. Contactable: jason.ukman@statnews.com

Austin, TX
Jason Ukman retweeted
This year, a loosely regulated clinical trial system in China gained global attention after the deaths of three patients. Now, a rare disease advocate says one of the only paths to creating drugs for desperate kids is being closed off. statnews.com/2026/11/05/chin…
5
11
1,010
New: In the five weeks since its approval, a pancreatic cancer drug shown to markedly extend survival time has been used to treat 5,000 patients who likely would have had no such reason to hope previously. Via @adamfeuerstein @statnews statnews.com/2026/11/05/raso…
1
179
Significant: Democratic scientists and clinicians have spent the past two years outraged and often powerless. Now, some of them are headed for public office. Via @AnilOza16 @SarahLizChar statnews.com/2026/11/04/midt…
13
8
1,805
Andrews’ election would mean there’s a Democratic physician in the Senate for the first time since 1969
NYT needle projects that Annie Andrews is likely to win South Carolina’s US Senate race.
7
28
2,276
🗳️ IT'S ELECTION DAY 🗳️ and my colleagues at @statnews have everything you need to know about health care in the midterms, starting with @_daniel_payne on the biggest ways votes cast today could change how you receive care: statnews.com/2026/10/31/midt…
1
13
15
2,935
An upcoming eczema trial readout from Kymera Therapeutics ($KYMR) is a crucial moment in the biotech's bid to rival Sanofi and Regeneron's Dupixent. For more context on the drug, study, and expectations, see my latest for @statnews statnews.com/2026/11/02/kyme…
1
1
5
707
Jason Ukman retweeted
3
11
20
3,613
Jason Ukman retweeted
@adamfeuerstein: So do you think that Dario at some point is going to find out that biology is going to kick his ass? Matt Gline, CEO of Roivant: I think Dario is going to find out that no one wants to go to an AI restaurant and eat an AI cheeseburger. That they want to go to an actual hospital and take an actual pill. #STATSummit
4
19
2,603
Jason Ukman retweeted
Matt Gline, Roivant CEO, on Anthropic's foray into biotech:
3
28
116
46,424
Jason Ukman retweeted
Science editor-in-chief Holden Thorpe gave the day’s first warning about the rise of science in China. He says he can see it in the papers researchers are trying to get published in the top scientific journal he edits. "Submissions from China continue to increase, not just in number but in quality, and submissions from the U.S. are going down,” Thorpe said. He later added: “The atmosphere there (China) is just so much more pro-science than it is here.” Here is a video.
20
57
138
41,780
Jason Ukman retweeted
I’m thrilled here to be here in Boston, one of my favorite cities on the planet, for today’s #STATSummit. Watch here for tweets and stories from STAT staff, or buy a virtual ticket… I’m very proud of this agenda. Here are some pictures from my jog the other day.
4
29
3,401
Fifty years ago, pioneering researcher Robert Gallo and his colleagues pursued basic research science and changed history. Sometimes you don't know where the work will lead. That, he writes in @statnews, is a lesson that should still matter. statnews.com/2026/10/09/robe…
1
4
5
616
Jason Ukman retweeted
U.S. health spending is on pace to cost almost $16,500 per person this year. And the biggest portion of an employer’s health spending — even for the largest corporations in the country — has remained the same since the 1980s: bit.ly/4edjsFi
1
3
1,692